Latest news:

Follicum receives patent approval in China

Follicum AB (“Follicum”) today announces that the Chinese Patent Office (SIPO) has granted the company’s patent application for stimulation of hair growth. Thanks to SIPO’s grant of patent number ZL 201280049850.X, Follicum has protection in China until 2032. The patent protects the company’s peptides in general and for the stimulation of hair growth specifically. CEO […]

Sign up for our Newsletter


Our drug candidates both inhibit and stimulate hair growth, and as they are based on endogenous proteins they are considered safe

Read more


The global market is over 15 billion USD a year and increasing, with few competitors to our drug candidates

Read more


We want to develop safe, effective and cost effective drugs, suitable for both men and women, that have minimal side effects

Read more




12 Mar 18
BIO Europe Spring

Follicum will attend the BIO Europe Spring Conference 12-14 March 2018 in Amsterdam, The Netherlands...

04 Jun 18
BIO International

Follicum will attend the BIO International Convention 4-7 June 2018 in Boston, USA More information...